Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesClinical/Medical PolicyWellfleet E/I/U Coverage Policy Update | OpenPayer
    Ask Trek AI about this page
    CurrentWellfleetPolicy GL-016

    Experimental/Investigational/Unproven

    Customize your policy alerts

    Sign up for wellfleet Policy GL-016 alerts

    Get alerted when Policy GL-016 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This payment guideline governs Wellfleet reimbursement for medical procedures, equipment, medications, testing, and cosmetic procedures identified as experimental, investigational, or unproven. It applies to claims under applicable Wellfleet plans and requires review of services that may fall within the E/I/U category.

    Policy Summary
    PayerWellfleet
    PolicyExperimental/Investigational/Unproven
    Policy CodePolicy GL-016
    Change TypeNo material change
    Effective DateAug 1, 2025
    Next Review DateJun 1, 2026
    Key ActionSubmit accurate claims and provide supporting documentation, including provider records, when requested.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Not coveredCoverage stance for services meeting the E/I/U definition
    3Core E/I/U determination criteria
    Category AFDA medical device category generally not covered
    NonexhaustiveE/I/U code list status
    URAC-certified IROOrganization used for utilization review determinations

    Experimental, Investigational, and Unproven Coverage Criteria

    Experimental/Investigational/Unproven determination

    A service is considered experimental, investigational, or unproven when ANY of the following apply:

    E/I/U criteria

    • Regulatory approval criterion: The service does not have unrestricted market approval from the Food and Drug Administration (FDA) or final approval from any other governmental regulatory body.
    • Evidence criterion: There is insufficient or inconclusive medical and scientific evidence to evaluate the service's therapeutic value.
    • Alternative-treatment criterion: The service is not medically necessary and a safe and medically accepted alternative is available.
    Policy Summary
    PayerWellfleet
    PolicyExperimental/Investigational/Unproven
    Policy CodePolicy GL-016
    Change TypeNo material change
    Effective DateAug 1, 2025
    Next Review DateJun 1, 2026
    Key ActionSubmit accurate claims and provide supporting documentation, including provider records, when requested.
    SourceLink
    On This Page
    Experimental, Investigational, and Unproven Coverage CriteriaClaims, Documentation, and ReviewGuideline BackgroundKey Definitions

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    FDA Category A device criterion: The service is a medical device established by the FDA as Category A, for which safety and effectiveness have not yet been established.FDA Category A

    Category A devices are generally not covered.

    Coverage standard

    Services and supplies are covered only when they are proven safe, efficacious, and comparable or superior to conventional services and supplies.

    Coverage standard: The service or supply is proven safe, efficacious, and comparable or superior to conventional services or supplies, and does not fall under the Experimental/Investigational/Unproven definition.

    Any service or supply that falls under the E/I/U definition is not a covered benefit.

    Services or supplies that meet the Experimental, Investigational, or Unproven (E/I/U) definition are not covered benefits. Wellfleet limits coverage to services and supplies proven safe, efficacious, and comparable or superior to conventional alternatives.

    FDA Category A medical devices are generally not covered. These devices have not yet had their safety and effectiveness established.

    A service is considered Experimental, Investigational, or Unproven (E/I/U) when it is not medically necessary and a safe, medically accepted alternative is available.

    Claims, Documentation, and Review

    Documentation Required

    Accurate Claims and Supporting Records

    Providers are responsible for submitting accurate claims. Wellfleet reserves the right to request supporting documentation for submitted claims, including provider records.

    Documentation Required

    Unlisted-Code Appeal Documentation

    Medical records submitted with an appeal related to an unlisted-code denial may be reviewed by Wellfleet’s contracted Internal Review Organization (IRO) for possible experimental, investigational, or unproven (E/I/U) status.

    Denial Risk

    E/I/U Services May Be Denied

    A service or supply that meets Wellfleet’s definition of experimental, investigational, or unproven (E/I/U) is not a covered benefit and may result in claim denial.

    Denial Risk

    IRO Determination Affects Payment and Review

    Wellfleet uses a contracted URAC-certified Internal Review Organization (IRO) to perform utilization reviews and determine whether a service is E/I/U. Wellfleet applies the IRO recommendation or determination to the claim payment decision, which may affect payment and the outcome of an appeal review.

    Guideline Background

    This guideline addresses services whose safety, efficacy, therapeutic value, regulatory approval, or medical necessity has not been established to Wellfleet’s standards. It applies to medical procedures, equipment, medications, testing, and cosmetic procedures, and limits coverage to services and supplies proven safe and efficacious and comparable or superior to conventional alternatives.

    Key Definitions

    Experimental/Investigational/Unproven (E/I/U)
    Applies toMedical procedures, equipment items, medications, and cosmetic procedures
    DefinitionA service that is not medically necessary and is not covered, and that meets at least one E/I/U criterion
    E/I/U criteriaCriteria include lack of required regulatory approval, insufficient or inconclusive evidence, availability of a safe and medically accepted alternative, or classification as an FDA Category A medical device
    E/I/U determination criteria
    Regulatory approvalThe service does not have unrestricted market approval from the FDA or final approval from another governmental regulatory body
    Medical and scientific evidenceThere is insufficient or inconclusive medical and scientific evidence to evaluate the service's therapeutic value
    Medical necessity and alternativesThe service is not medically necessary and a safe and medically accepted alternative is available
    FDA device classificationThe service is a medical device established by the FDA as Category A, for which safety and effectiveness have not yet been established
    FDA Category A medical device
    DefinitionA medical device established by the FDA as Category A
    Safety and effectivenessThe device's safety and effectiveness have not yet been established
    General coverage statusCategory A medical devices are generally not covered